Implantable cardioverter defibrillator lead endocarditis causing diffuse right atrial abscess and pulmonary artery embolism.
Implantation of electrophysiological cardiac devices such as pacemakers and implantable cardioverter defibrillators has become a widely available and routine procedure in cardiovascular medicine. One of the most feared complications of device implementation is infection. Infection rates for these devices are reported to vary between 0.7% and 7.0%. Cardiac thromboembolic event is a recognized complication of permanent cardiac rhythm devices with an incidence of 0.6%-3.5%, unrelated to lead size or number. These complications are associated with high morbidity and mortality rates. In this case report, right atrial mass, right atrial abscess, perforation of tricuspid septal leaflet, and pulmonary embolism secondary to ICD lead endocarditis is presented.
Kervan
Ümit
Ü
Cardiovascular Surgery, Yuksek Ihtisas Hospital of Turkey, Ankara, Turkey. drukervan@yahoo.com
Altintas
Garip
G
Ozen
Anil
A
Durukan
Mine
M
Guray
Ümit
Ü
Özatik
Mehmet Ali
MA
D000038:Abscess / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000382:microbiology*; D004696:Endocarditis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D017809:Fatal Outcome; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging / Q000382:microbiology; D006801:Humans; D008875:Middle Aged; D011651:Pulmonary Artery / Q000000981:diagnostic imaging; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000000981:diagnostic imaging; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy; D014463:Ultrasonography; D014693:Ventricular Fibrillation / Q000628:therapy
D000900:Anti-Bacterial Agents